This nomogram provides individualized OS prediction for CRCLM patients treated with resection and chemotherapy. However, limitations include the lack of external validation, exclusion of chemotherapy regimens/molecular markers, and potential socioeconomic confounders affecting race associations. Future studies should incorporate treatment-specific variables and validate the model in diverse cohorts to enhance generalizability.